A-Z of Understanding Global Childhood Cancer, International Organizations, Research & Advocacy Terms

​

Access to Care

Access to care refers to a child's ability to obtain timely, affordable, and appropriate healthcare services. In childhood cancer, access to care can influence how quickly a child is diagnosed, whether treatment is available, and the likelihood of achieving a successful outcome. Barriers such as geography, poverty, transportation challenges, workforce shortages, and limited healthcare infrastructure continue to affect many families worldwide. Improving access to care remains a major priority in global childhood cancer control efforts.

​

Cancer Equity

Cancer equity refers to the principle that every child should have an equal opportunity to receive quality cancer care regardless of their location, income, ethnicity, gender, or social circumstances. Significant disparities continue to exist between high-income and low-income countries, with survival rates often differing substantially. Global efforts to improve cancer equity focus on expanding access to diagnosis, treatment, medicines, supportive care, and survivorship services.

​

Capacity Building

Capacity building involves strengthening healthcare systems, institutions, infrastructure, and workforce capabilities to improve childhood cancer care. This may include healthcare professional training, educational programs, resource development, technology transfer, and investment in medical facilities. Capacity building is a key strategy for improving outcomes in countries where pediatric oncology services remain limited or underdeveloped.

​

Childhood Cancer

Childhood cancer refers to cancers diagnosed in children and adolescents. Unlike many adult cancers, childhood cancers are generally not linked to lifestyle factors and often arise from developmental or genetic abnormalities. Although childhood cancers are relatively rare, they remain a leading cause of disease-related death among children worldwide. Advances in treatment have significantly improved survival rates, particularly in high-income countries.

​

Childhood Cancer Advocacy

Childhood cancer advocacy involves efforts to improve awareness, healthcare policy, funding, research investment, patient support, and access to treatment for children affected by cancer. Advocacy organizations work with governments, healthcare systems, researchers, and international partners to ensure that childhood cancer remains a public health priority. Effective advocacy can lead to improved services, better treatment access, and stronger support for families

.

Childhood Cancer Awareness

Childhood cancer awareness focuses on educating communities, healthcare professionals, policymakers, and families about the signs, symptoms, and challenges associated with childhood cancer. Increased awareness can support earlier diagnosis, reduce treatment delays, encourage healthcare engagement, and strengthen public support for research and patient services. Awareness campaigns are often coordinated through hospitals, charities, advocacy organizations, and international health agencies.

​

Childhood Cancer Control

Childhood cancer control refers to coordinated strategies aimed at reducing the burden of childhood cancer through prevention where possible, early diagnosis, effective treatment, supportive care, survivorship services, and health system strengthening. Comprehensive cancer control programs help improve survival outcomes and quality of life for children diagnosed with cancer around the world.

​

Childhood Cancer International (CCI)

Children's Cancer International is the world's largest childhood cancer patient support organization, representing hundreds of parent groups, survivor organizations, and childhood cancer advocates across multiple countries. CCI works to improve awareness, support services, patient representation, and policy engagement while amplifying the voices of children, survivors, and families affected by childhood cancer.

​

Clinical Trial

A clinical trial is a carefully designed research study that evaluates new treatments, therapies, medical devices, supportive care approaches, or healthcare interventions. Clinical trials play an essential role in advancing pediatric oncology by helping researchers identify safer, more effective treatments for childhood cancers such as Wilms tumor. Participation in clinical trials may provide access to emerging therapies and contribute to future improvements in patient care.

​

CureAll Framework

The CureAll Framework is a global childhood cancer strategy developed by the World Health Organization as part of efforts to improve childhood cancer survival worldwide. The framework emphasizes four key pillars: Centres of Excellence, Universal Health Coverage, Treatment Regimens, and Evaluation & Monitoring Systems. CureAll serves as a roadmap for countries seeking to strengthen childhood cancer services and improve outcomes for children with cancer.

​

Early Diagnosis

Early diagnosis refers to the prompt identification and confirmation of cancer before significant disease progression occurs. In childhood cancer, early diagnosis can reduce treatment complexity, improve survival rates, lower treatment-related complications, and improve quality of life. Global awareness programs increasingly focus on educating healthcare professionals and communities to recognize early warning signs of childhood cancers such as Wilms tumor.

​

Evidence-Based Medicine

Evidence-based medicine is the practice of making healthcare decisions using the best available scientific evidence combined with clinical expertise and patient preferences. In pediatric oncology, evidence-based medicine helps guide treatment protocols, supportive care strategies, survivorship recommendations, and research priorities. This approach ensures that children receive care based on proven effectiveness and current medical knowledge.

​

Global Childhood Cancer

Global childhood cancer refers to efforts aimed at improving outcomes for children with cancer across all regions of the world. These efforts include healthcare system strengthening, professional education, access to medicines, research collaboration, patient support, advocacy, and policy development. International partnerships are increasingly important in addressing disparities in childhood cancer survival between countries and regions.

​

Global Initiative for Childhood Cancer (GICC)

The Global Initiative for Childhood Cancer is a worldwide program led by the World Health Organization in partnership with organizations including St. Jude Children's Research Hospital. The initiative aims to increase childhood cancer survival globally while reducing suffering and improving access to quality care. The GICC provides guidance, technical support, and strategic frameworks for countries seeking to strengthen pediatric oncology services.

​

Global Oncology

Global oncology is a field of medicine focused on reducing disparities in cancer prevention, diagnosis, treatment, and survivorship across different countries and healthcare systems. Global oncology initiatives often address workforce development, healthcare infrastructure, treatment access, policy development, and international collaboration. The field plays an important role in improving childhood cancer outcomes worldwide.

​

Health Systems Strengthening

Health systems strengthening involves improving the performance, capacity, and resilience of healthcare systems. In childhood cancer, this may include workforce training, infrastructure development, improved referral systems, access to medicines, diagnostic services, and quality improvement initiatives. Strong healthcare systems are essential for delivering effective and sustainable pediatric oncology care.

​

International Agency for Research on Cancer (IARC)

The International Agency for Research on Cancer is the specialized cancer research agency of the World Health Organization. IARC conducts and coordinates research on cancer causes, prevention strategies, epidemiology, and public health. Its work contributes to a better understanding of cancer patterns and supports evidence-based approaches to cancer control worldwide.

​

International Society of Paediatric Oncology (SIOP)

The International Society of Paediatric Oncology is the leading international professional organization dedicated to improving outcomes for children and adolescents with cancer. SIOP supports research, education, clinical collaboration, guideline development, and professional networking. Its work has significantly influenced global Wilms tumor treatment protocols and pediatric oncology practice.

​

Pediatric Oncology

Pediatric oncology is the branch of medicine dedicated to the diagnosis, treatment, and management of cancers affecting children and adolescents. Pediatric oncologists work alongside multidisciplinary teams to provide comprehensive care that addresses both the medical and psychosocial needs of young patients. The specialty has achieved remarkable advances in survival through research, innovation, and international collaboration.

​

Precision Medicine

Precision medicine is an approach to healthcare that tailors treatment according to an individual's genetic, biological, and clinical characteristics. In pediatric oncology, precision medicine may involve genetic testing, molecular profiling, and targeted therapies designed to improve treatment effectiveness while minimizing unnecessary side effects. Ongoing research continues to expand the role of precision medicine in childhood cancer care.

​

Research Collaboration

Research collaboration involves cooperation between scientists, clinicians, healthcare institutions, advocacy organizations, and governments to advance medical knowledge and improve patient outcomes. Collaborative research has played a critical role in improving survival rates for Wilms tumor and other childhood cancers. International partnerships allow researchers to share expertise, resources, and data more effectively.

​

SIOP Renal Tumour Study Group (RTSG)

The SIOP Renal Tumour Study Group is a specialist group within SIOP dedicated to research and clinical guidance relating to Wilms tumor and other pediatric renal tumors. The group develops treatment protocols, conducts clinical studies, and supports international collaboration aimed at improving outcomes for children with kidney cancers.

​

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is one of the world's leading pediatric cancer research and treatment institutions. The organization plays a major role in global childhood cancer initiatives through research, education, clinical collaboration, and partnerships supporting healthcare capacity building. St. Jude is a key partner in the Global Initiative for Childhood Cancer.

​

Targeted Therapy

Targeted therapy refers to treatments that specifically attack molecular features or biological pathways involved in cancer growth. Unlike traditional chemotherapy, targeted therapies are designed to focus on cancer-related mechanisms while minimizing damage to healthy cells. Although targeted therapies are not yet widely used in standard Wilms tumor treatment, ongoing research continues to explore their potential role.

​

Treatment Abandonment

Treatment abandonment occurs when a child fails to start or complete recommended cancer treatment. It is a major challenge in many low- and middle-income countries and may result from financial hardship, travel barriers, limited healthcare access, cultural beliefs, or inadequate support systems. Reducing treatment abandonment is considered one of the most important priorities in global childhood cancer care because it can significantly improve survival outcomes.

​

Universal Health Coverage (UHC)

Universal Health Coverage (UHC) is the principle that all people should have access to quality healthcare services without experiencing financial hardship. Universal health coverage is a central component of global health policy and plays an important role in improving childhood cancer outcomes. Expanding access to affordable diagnosis, treatment, medicines, and survivorship services can help reduce disparities and improve survival rates worldwide.

​

World Health Organization (WHO)

The World Health Organization is the specialized health agency of the United Nations and the leading international authority on global public health. The WHO works with governments, healthcare organizations, researchers, and partners to address health challenges worldwide, including childhood cancer. Through initiatives such as the Global Initiative for Childhood Cancer and the CureAll Framework, the WHO supports efforts to improve diagnosis, treatment, survivorship, and outcomes for children affected by cancer globally.